Back to search

Denmark· DK-28106909223

Klorzoxazon "Evolan"

A chlorzoxazone product containing chlorzoxazon, registered in Denmark by Evolan Pharma AB. The same ATC class is registered in 3 of our 19 countries.

ATC M03BB03

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedKlorzoxazon "Evolan"ATCM03BB03REGISTER NO.DK-28106909223PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Chlorzoxazone is registered in 3 of 19 countries.

Countries holding a registration under ATC M03BB03 (chlorzoxazone), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 2 of them publish a price we can compare per daily dose

Chlorzoxazone · ATC M03BB03

3 / 19 countries

  • Denmark
  • Norwayprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
CHLORZOXAZON
Manufacturer
Evolan Pharma AB
Country
Denmark (DK)
ATC code
M03BB03
ATC class
Chlorzoxazone
Defined daily dose
1.5 g, O
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28106909223

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

92 interactions on record for chlorzoxazone.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Chlorzoxazone · interactions on record

92 records

  • 8 severe
  • 64 moderate
  • 20 info

Most severe, free to view

  • LeflunomidL04AA13severe
  • TeriflunomidL04AA31severe
  • LeflunomideL04AK01severe
  • TeriflunomideL04AK02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b4684ee1-8776-4d72-a5e8-9f3c95754b04
GET /v1/drugs/b4684ee1-8776-4d72-a5e8-9f3c95754b04?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "tabletter",
  "source": "dkma",
  "strength": "250 mg",
  "auth_role": "DKMA",
  "dk_drugid": "28106909223",
  "substance": "CHLORZOXAZON",
  "auth_procedure": "National",
  "in_medicinpriser": false,
  "registration_date_serial": "45750"
}

See everything about chlorzoxazone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.